Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C9H12ClN3O4S2 |
| Molecular Weight | 325.792 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCC1NC2=CC(Cl)=C(C=C2S(=O)(=O)N1)S(N)(=O)=O
InChI
InChIKey=VXLCNTLWWUDBSO-UHFFFAOYSA-N
InChI=1S/C9H12ClN3O4S2/c1-2-9-12-6-3-5(10)7(18(11,14)15)4-8(6)19(16,17)13-9/h3-4,9,12-13H,2H2,1H3,(H2,11,14,15)
| Molecular Formula | C9H12ClN3O4S2 |
| Molecular Weight | 325.792 |
| Charge | 0 |
| Count |
|
| Stereochemistry | RACEMIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Optical Activity | ( + / - ) |
DescriptionSources: http://www.google.je/patents/EP1125586A1?cl=en
Sources: http://www.google.je/patents/EP1125586A1?cl=en
Ethiazide is a diuretic.
Originator
Sources: http://www.google.je/patents/EP1125586A1?cl=en
Curator's Comment: Now is a part of Mitsubishi Tanabe Pharma.
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Interaction of benzothiadiazides with human serum albumin studied by dialysis and spectroscopic methods. | 1994-10 |
|
| Epimerization and racemization of some chiral drugs in the presence of human serum albumin. | 1990-01 |
|
| Epimerization and racemization of some chiral drugs in the presence of cyclodextrin and liposomes. | 1989-10 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:02:30 GMT 2025
by
admin
on
Mon Mar 31 18:02:30 GMT 2025
|
| Record UNII |
EK9LSW731R
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C49185
Created by
admin on Mon Mar 31 18:02:30 GMT 2025 , Edited by admin on Mon Mar 31 18:02:30 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
1648
Created by
admin on Mon Mar 31 18:02:30 GMT 2025 , Edited by admin on Mon Mar 31 18:02:30 GMT 2025
|
PRIMARY | |||
|
SUB07275MIG
Created by
admin on Mon Mar 31 18:02:30 GMT 2025 , Edited by admin on Mon Mar 31 18:02:30 GMT 2025
|
PRIMARY | |||
|
CHEMBL2106262
Created by
admin on Mon Mar 31 18:02:30 GMT 2025 , Edited by admin on Mon Mar 31 18:02:30 GMT 2025
|
PRIMARY | |||
|
100000082597
Created by
admin on Mon Mar 31 18:02:30 GMT 2025 , Edited by admin on Mon Mar 31 18:02:30 GMT 2025
|
PRIMARY | |||
|
C80840
Created by
admin on Mon Mar 31 18:02:30 GMT 2025 , Edited by admin on Mon Mar 31 18:02:30 GMT 2025
|
PRIMARY | |||
|
15763
Created by
admin on Mon Mar 31 18:02:30 GMT 2025 , Edited by admin on Mon Mar 31 18:02:30 GMT 2025
|
PRIMARY | |||
|
1824-58-4
Created by
admin on Mon Mar 31 18:02:30 GMT 2025 , Edited by admin on Mon Mar 31 18:02:30 GMT 2025
|
PRIMARY | |||
|
m723
Created by
admin on Mon Mar 31 18:02:30 GMT 2025 , Edited by admin on Mon Mar 31 18:02:30 GMT 2025
|
PRIMARY | Merck Index | ||
|
EK9LSW731R
Created by
admin on Mon Mar 31 18:02:30 GMT 2025 , Edited by admin on Mon Mar 31 18:02:30 GMT 2025
|
PRIMARY | |||
|
DTXSID1046215
Created by
admin on Mon Mar 31 18:02:30 GMT 2025 , Edited by admin on Mon Mar 31 18:02:30 GMT 2025
|
PRIMARY | |||
|
217-358-0
Created by
admin on Mon Mar 31 18:02:30 GMT 2025 , Edited by admin on Mon Mar 31 18:02:30 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ENANTIOMER -> RACEMATE | |||
|
|
ENANTIOMER -> RACEMATE |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |